CASPER MARC N 4

Accession 0000097745-25-000152

CIK 0000097745other

View on SEC.gov Company Profile

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 4:27 PM ET

Size

40.8 KB

Accession

0000097745-25-000152

Insider Transaction Report

Form 4

Period: 2025-10-24

THERMO FISHER SCIENTIFIC INC.TMO

CASPER MARC N

Chief Operating Officer

Transactions

Sale
Common Stock
2025-10-27$571.99/sh−348$199,053→ 113,762.285 total
Sale
Common Stock
2025-10-27$567.57/sh−141$80,027→ 115,697.285 total
Sale
Common Stock
2025-10-27$563.72/sh−1,193$672,518→ 119,469.285 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-10-27−7,250→ 0 total
Exercise: $253.99Exp: 2026-02-26→ Common Stock (7,250 underlying)
Sale
Common Stock
2025-10-27$570.91/sh−728$415,622→ 114,110.285 total
Sale
Common Stock
2025-10-24$571.30/sh−1,249$713,554→ 129,617.285 total
Sale
Common Stock
2025-10-24$573.37/sh−4,762$2,730,388→ 122,386.285 total
Sale
Common Stock
2025-10-24$572.28/sh−2,469$1,412,959→ 127,148.285 total
Exercise/Conversion
Common Stock
2025-10-27$253.99/sh+7,250$1,841,428→ 121,012.285 total
Sale
Common Stock
2025-10-27$562.63/sh−241$135,594→ 120,662.285 total
Sale
Common Stock
2025-10-27$565.47/sh−937$529,845→ 116,019.285 total
Sale
Common Stock
2025-10-27$566.47/sh−181$102,531→ 115,838.285 total
Exercise/Conversion
Common Stock
2025-10-24$253.99/sh+17,104$4,344,245→ 130,866.285 total
Sale
Common Stock
2025-10-24$574.20/sh−7,331$4,209,460→ 115,055.285 total
Sale
Common Stock
2025-10-24$575.02/sh−1,293$743,501→ 113,762.285 total
Sale
Common Stock
2025-10-27$561.68/sh−109$61,223→ 120,903.285 total
Sale
Common Stock
2025-10-27$564.44/sh−2,513$1,418,438→ 116,956.285 total
Sale
Common Stock
2025-10-27$568.98/sh−189$107,537→ 115,508.285 total
Sale
Common Stock
2025-10-27$569.93/sh−670$381,853→ 114,838.285 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-10-24−17,104→ 7,250 total
Exercise: $253.99Exp: 2026-02-26→ Common Stock (17,104 underlying)

Holdings

Common Stock
(indirect: By Floral Park Associates, Inc.)
14,608
Common Stock
(indirect: By Trust)
5,000
Common Stock
(indirect: By Trust)
11,300

Footnotes (20)

[F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2025.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.08 to $565.07, inclusive.
[F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.08 to $565.97, inclusive.
[F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.14 to $566.68, inclusive.
[F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.14 to $568.13, inclusive.
[F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.32 to $569.27, inclusive.
[F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.42 to $570.41, inclusive.
[F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.43 to $571.39, inclusive.
[F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.48 to $572.27, inclusive.
[F18]The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
[F19]The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.73 to $571.72, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16) and (17) to this Form 4.
[F20]The option vests in four equal annual installments beginning on February 26, 2020.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.75 to $572.74, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.75 to $573.74, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.76 to $574.75, inclusive.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.76 to $575.67, inclusive.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.04 to $561.97, inclusive.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $562.07 to $563.02, inclusive.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.08 to $564.07, inclusive.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

THERMO FISHER SCIENTIFIC INC.

CIK 0000097745

→

Entity typeother

Related Parties

filerCIK 0001216055

Filing Metadata

Form type: 4
Filed: Oct 27, 8:00 PM ET
Accepted: Oct 28, 4:27 PM ET
Size: 40.8 KB

View on SEC.gov